A study held for pain management by homoeopathic medicines in cases of migraine by using MIDAS scale

Effectiveness of individualized homoeopathic medicines in pain management in cases of migraine using MIDAS scale

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043536

Enrollment

Registered

2022-06-28

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: Individualized Homoeopathic medicine: administered through oral route in 6c 30 200 1M potency according to the patient symptom similarity and susceptibility for 7/15 days upto 3months C

Eligibility

Inclusion criteria

Inclusion criteria: Patient suffering from sign and symptoms suggestive of Migraine on the basis of clinical history and findings Previously Diagnosed cases of Migraine reoccurring, with other medicines with no improvement Patients of age groups of more than 18 and both the sexes will be considered

Exclusion criteria

Exclusion criteria: Cases with complication of Migraine like status migrainosus drug induced diseases

Design outcomes

Primary

Measure	Time frame
To assess effectiveness of individualized homoeopathic medicines in pain management in the cases of Migraine using MIDAS scaleTimepoint: 3months	—

Secondary

Measure	Time frame
To compare extent of improvement in quality of life of patients treated with individualized homoeopathic medicines in the cases of Migraine using MIDAS scale Timepoint: QOL score upto 4 visits	—

Countries

India

Contacts

Public ContactDr Anandita Debnath

Homoeopathy University

drvirendrachauhan34@gmail.com9983548853

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026